VAQTA ®(Hepatitis A Vaccine, Inactivated) Suspension for Intramuscular Injection Initial U.S. Approval: 1996 These highlights do not include all the information needed to use VAQTA safely and effectively. See full prescribing information for VAQTA.

VAQTA by

Drug Labeling and Warnings

VAQTA by is a Other medication manufactured, distributed, or labeled by Bamboo US BidCo LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

VAQTA- hepatitis a vaccine, inactivated injection, suspension 
Bamboo US BidCo LLC

----------

VAQTA ®(Hepatitis A Vaccine, Inactivated)
Suspension for Intramuscular Injection
Initial U.S. Approval: 1996

These highlights do not include all the information needed to use VAQTA safely and effectively. See full prescribing information for VAQTA.

PRINCIPAL DISPLAY PANEL - 0.5 mL Syringes Carton

10 Single-Dose 0.5-mL Syringes

[HEPATITIS A VACCINE,
INACTIVATED]
VAQTA ®

PEDIATRIC/ADOLESCENT
FORMULATION

This package contains 10 single-dose syringes.
Each 0.5-mL syringe contains approximately 25U of hepatitis A virus antigen
on an amorphous aluminum hydroxyphosphate sulfate adjuvant.

Hepatitis A virus is grown in cell culture in human MRC-5 diploid fibroblasts.

Rx only

PRINCIPAL DISPLAY PANEL - 1 mL Syringes Carton

10 Single-Dose 1-mL Syringes

[HEPATITIS A VACCINE,
INACTIVATED]
VAQTA ®

ADULT FORMULATION

This package contains 10 single-dose syringes.
Each 1-mL syringe contains approximately 50U of hepatitis A virus antigen
on an amorphous aluminum hydroxyphosphate sulfate adjuvant.

Hepatitis A virus is grown in cell culture in human MRC-5 diploid fibroblasts.

Rx only

VAQTA 
hepatitis a vaccine, inactivated injection, suspension

Product Information
Product Type	VACCINE	Item Code (Source)	NDC: 83703-045
Route of Administration	INTRAMUSCULAR

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: Q04Q922K9Q) (HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) - UNII:Q04Q922K9Q)	HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)	25 [iU]  in 0.5 mL

Inactive Ingredients
Ingredient Name	Strength
SODIUM BORATE (UNII: 91MBZ8H3QO)	35 ug  in 0.5 mL
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)

Product Characteristics
Color	white (slightly opaque, white)	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83703-045-01	0.5 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
BLA	BLA103606	03/29/1996

VAQTA 
hepatitis a vaccine, inactivated injection, suspension

Product Information
Product Type	VACCINE	Item Code (Source)	NDC: 83703-046
Route of Administration	INTRAMUSCULAR

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: Q04Q922K9Q) (HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) - UNII:Q04Q922K9Q)	HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)	50 [iU]  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
SODIUM BORATE (UNII: 91MBZ8H3QO)	70 ug  in 1 mL
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WATER (UNII: 059QF0KO0R)

Product Characteristics
Color	white (slightly opaque, white)	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83703-046-01	1 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
BLA	BLA103606	03/29/1996

Labeler - Bamboo US BidCo LLC (119087615)

Revised: 6/2025

Document Id: 387ef45e-0f6c-9744-e063-6294a90ab403

53404-0

Set id: 1a8b7b47-d5f8-e6b5-e063-6394a90a9ac4

Version: 5

Effective Time: 20250626